NEW YORK (GenomeWeb) – GenMark Diagnostics announced today that it expects to post a 7 percent increase its fourth quarter revenues on strong sales of its ePlex molecular diagnostics systems.
NEW YORK (GenomeWeb) – GenMark Diagnostics announced today that it expects to post a 7 percent increase its fourth quarter revenues on strong sales of its ePlex molecular diagnostics systems.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.